eglumetad and fg 9041
eglumetad has been researched along with fg 9041 in 2 studies
Compound Research Comparison
| Studies (eglumetad) | Trials (eglumetad) | Recent Studies (post-2010) (eglumetad) | Studies (fg 9041) | Trials (fg 9041) | Recent Studies (post-2010) (fg 9041) |
|---|---|---|---|---|---|
| 190 | 5 | 48 | 812 | 0 | 122 |
Protein Interaction Comparison
| Protein | Taxonomy | eglumetad (IC50) | fg 9041 (IC50) |
|---|---|---|---|
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.998 | |
| Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.998 | |
| Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.998 | |
| fatty acid synthase | Homo sapiens (human) | 7.755 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor 1 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor 2 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor 3 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor 4 | Homo sapiens (human) | 1.51 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.1 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.1 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Capogna, M | 1 |
| Capogna, M; Kerr, AM | 1 |
Other Studies
2 other study(ies) available for eglumetad and fg 9041
| Article | Year |
|---|---|
Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs.
Topics: Amino Acids; Aminobutyrates; Animals; Bridged Bicyclo Compounds; Calcium Channel Blockers; Cyclic AMP; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Elapid Venoms; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Hippocampus; In Vitro Techniques; Membrane Potentials; Neural Inhibition; omega-Conotoxin GVIA; Perforant Pathway; Phosphinic Acids; Propanolamines; Quinoxalines; Rats; Receptors, Metabotropic Glutamate; Statistics, Nonparametric; Synaptic Transmission; Thionucleotides; Time Factors; Xanthenes | 2004 |
Unitary IPSPs enhance hilar mossy cell gain in the rat hippocampus.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Bridged Bicyclo Compounds; Cell Membrane; Electric Capacitance; Electric Impedance; Excitatory Postsynaptic Potentials; Hippocampus; Inhibitory Postsynaptic Potentials; Interneurons; Male; Mossy Fibers, Hippocampal; Neurons; Patch-Clamp Techniques; Pilocarpine; Pyridazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Sodium Channels; Synaptic Transmission; Tetrodotoxin | 2007 |